Skip to main content

IPHA · Innate Pharma SA · Short Interest

Track IPHA — free
$1.39 +0.06 (+4.51%) Play latest call Q2 2026 earnings call transcript
Market Cap
$148.56M
Shares
111.70M
Volume · Nov 4 10.67K Avg daily vol (3M) 158.14K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

IPHA Latest Reported Short Interest

FINRA reported 126,864 IPHA shares sold short as of the October 15, 2026 settlement date, an increase of 38,242 shares. Days to cover was 2.64 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

Short Squeeze Score
56/100
Short interest 0.1% of shares — P21 Days to cover 2.6 — P42 Price vs VWAP -33.5% — P11 Short-volume trend +37.9% — P98 Short interest change +43.2% — P91 Worst FTD 0.01% of shares — P56 Earnings soon +10

Positioning score 45.9 + catalyst boost 10 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-10-15). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

No active listed options were found.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-11-04 22:05 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-11-13 Scheduled
FINRA publishes Nov 24
— — — —
2026-10-30 Scheduled
FINRA publishes Nov 10
— — — —
2026-10-15 126,864 88,622 +38,242 2.64
2026-09-30 88,622 76,073 +12,549 1.25
2026-09-15 76,073 81,961 -5,888 4.09
2026-08-31 81,961 227,041 -145,080 1.81
2026-08-14 227,041 152,432 +74,609 1.00
2026-07-31 152,432 163,552 -11,120 27.54
2026-07-15 163,552 179,942 -16,390 22.81
2026-06-30 179,942 209,331 -29,389 14.56
2026-06-15 209,331 193,882 +15,449 3.45
2026-05-29 193,882 245,729 -51,847 5.02
2026-05-15 245,729 90,515 +155,214 1.04
2026-04-30 90,515 64,220 +26,295 3.86
2026-04-15 64,220 71,264 -7,044 2.28
2026-03-31 71,264 76,183 -4,919 3.13
2026-03-13 76,183 99,192 -23,009 4.42
2026-02-27 99,192 125,617 -26,425 7.28
2026-02-13 125,617 210,405 -84,788 6.04
2026-01-30 210,405 227,571 -17,166 8.29
2026-01-15 227,571 242,455 -14,884 15.18
2025-12-31 242,455 241,070 +1,385 6.62
2025-12-15 241,070 241,759 -689 15.02
2025-11-28 241,759 220,987 +20,772 9.51
2025-11-14 220,987 57,894 +163,093 1.00

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 1598599 CUSIP 45781K204 13F (30d) 4 filings 4 filers Visit website Investor relations